inclusion criteria: * positive for covid-19 with any approved rt-pcr or rapid antigen test within 7 days of planned treatment * have mild illness/symptoms based upon nih criteria. the nih illness severity definition for "mild" states as follows: "individuals who have any of the various signs and symptoms of covid-19 (e.g., fever, cough, sore throat, malaise, headache, muscle pain, nausea, vomiting, diarrhea, loss of taste and smell) but who do not have shortness of breath, dyspnea, or abnormal chest imaging." * be in good health as judged by investigator using screening medical history and physical examination. participants who are otherwise healthy with a stable chronic medical condition may enroll * a prior covid-19 infection in the past from which the subject fully recovered or a previously unknown asymptomatic infection is allowed, as is any previous covid-19 vaccination * must be willing and able to comply with all planned study procedures and be available for all study visits and follow-up as required by the protocol * subject must have provided written informed consent which includes signing the institutional review board or independent ethics committee approved consent form prior to participating in any study related activity * willing to follow contraception guidelines

inclusion criteria: * positive for covid-19 with any approved rt-pcr or rapid antigen test within 7 days of planned treatment * have mild illness/symptoms based upon nih criteria. the nih illness severity definition for "mild" states as follows: "individuals who have any of the various signs and symptoms of covid-19 (e.g., fever, cough, sore throat, malaise, headache, muscle pain, nausea, vomiting, diarrhea, loss of taste and smell) but who do not have shortness of breath, dyspnea, or abnormal chest imaging." * be in good health as judged by investigator using screening medical history and physical examination. participants who are otherwise healthy with a stable chronic medical condition may enroll * a prior covid-19 infection in the past from which the subject fully recovered or a previously unknown asymptomatic infection is allowed, as is any previous covid-19 vaccination * must be willing and able to comply with all planned study procedures and be available for all study visits and follow-up as required by the protocol * subject must have provided written informed consent which includes signing the institutional review board or independent ethics committee approved consent form prior to participating in any study related activity * willing to follow contraception guidelines

inclusion criteria: - positive for covid-19 with any approved rt-pcr or rapid antigen test within 7 days of planned treatment - have mild illness/symptoms based upon nih criteria. the nih illness severity definition for "mild" states as follows: "individuals who have any of the various signs and symptoms of covid-19 (e.g., fever, cough, sore throat, malaise, headache, muscle pain, nausea, vomiting, diarrhea, loss of taste and smell) but who do not have shortness of breath, dyspnea, or abnormal chest imaging." - be in good health as judged by investigator using screening medical history and physical examination. participants who are otherwise healthy with a stable chronic medical condition may enroll - a prior covid-19 infection in the past from which the subject fully recovered or a previously unknown asymptomatic infection is allowed, as is any previous covid-19 vaccination - must be willing and able to comply with all planned study procedures and be available for all study visits and follow-up as required by the protocol - subject must have provided written informed consent which includes signing the institutional review board or independent ethics committee approved consent form prior to participating in any study related activity - willing to follow contraception guidelines

inclusion criteria: - positive for covid-19 with any approved rt-pcr or rapid antigen test within 7 days of planned treatment - have mild illness/symptoms based upon nih criteria. the nih illness severity definition for "mild" states as follows: "individuals who have any of the various signs and symptoms of covid-19 (e.g., fever, cough, sore throat, malaise, headache, muscle pain, nausea, vomiting, diarrhea, loss of taste and smell) but who do not have shortness of breath, dyspnea, or abnormal chest imaging." - be in good health as judged by investigator using screening medical history and physical examination. participants who are otherwise healthy with a stable chronic medical condition may enroll - a prior covid-19 infection in the past from which the subject fully recovered or a previously unknown asymptomatic infection is allowed, as is any previous covid-19 vaccination - must be willing and able to comply with all planned study procedures and be available for all study visits and follow-up as required by the protocol - subject must have provided written informed consent which includes signing the institutional review board or independent ethics committee approved consent form prior to participating in any study related activity - willing to follow contraception guidelines